Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Schneider, Christian P ^a   Angele, Martin K ^a   Hartl, Wolfgang H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY BYPASS; DIAGNOSTIC ACCURACY; DISEASE MARKER; HUMAN; NOTE; PARTIAL THROMBOPLASTIN TIME; POPULATION RESEARCH; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WAVEFORM; BLOOD; CORONARY ARTERY BYPASS GRAFT; LETTER; SEPSIS;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; HUMANS; PARTIAL THROMBOPLASTIN TIME; SEPSIS;

EID: 77956628552     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8226     Document Type: Note

References (16)

1. Delannoy B, Guye ML, Slaiman DH, Lehot JJ, Cannesson M. Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations. Crit Care 2009, 13:R180. 10.1186/cc8166, 19912638.
2. Cislaghi F, Condemi AM, Corona A. Predictors of prolonged mechanical ventilation in a cohort of 5123 cardiac surgical patients. Eur J Anaesthesiol 2009, 26:396-403. 10.1097/EJA.0b013e3283232c69, 19276979.
3. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury 2007, 38:1336-1345. 10.1016/j.injury.2007.10.003, 18048040.
4. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, . International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine.
5. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003. 10.1097/01.CCM.0000226413.54364.36, 16715031.
6. Schneider CP, Yilmaz Y, Kleespies A, Jauch KW, Hartl WH. Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients. Shock 2009, 31:568-673. 10.1097/SHK.0b013e318193cb52, 19008783.
7. Dornbusch HJ, Strenger V, Kerbl R, Lackner H, Schwinger W, Sovinz P, Urban C. Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis. Bone Marrow Transplant 2003, 32:941-945. 10.1038/sj.bmt.1704265, 14561996.
8. Stucker F, Herrmann F, Graf JD, Michel JP, Krause KH, Gavazzi G. Procalcitonin and infection in elderly patients. J Am Geriatr Soc 2005, 53:1392-1395. 10.1111/j.1532-5415.2005.53421.x, 16078967.
9. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and metaanalysis. Lancet Infect Dis 2007, 7:210-217. 10.1016/S1473-3099(07)70052-X, 17317602.
10. Brunkhorst FM, Eberhard OK, Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999, 27:2172-2176. 10.1097/00003246-199910000-00016, 10548201.
11. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, Kushimoto S, Yukioka H, Kato N, Totsuka K, Kikuchi K, Ikeda T, Ikeda K, Harada K, Satomura S. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005, 11:152-159. 10.1007/s10156-005-0388-9, 15990980.
12. Sierra R, Rello J, Bailén MA, Benítez E, Gordillo A, León C, Pedraza S. C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med 2004, 30:2038-2045. 10.1007/s00134-004-2434-y, 15378239.
13. Dempfle CE, Borggrefe M. The hidden sepsis marker: aPTT waveform analysis. Thromb Haemost 2008, 100:9-10.
14. Chopin N, Floccard B, Sobas F, Illinger J, Boselli E, Benatir F, Levrat A, Guillaume C, Crozon J, Négrier C, Allaouchiche B. Activated partial thromboplastin time waveform analysis: a new tool to detect infection?. Crit Care Med 2006, 34:1654-1660. 10.1097/01.CCM.0000217471.12799.1C, 16607236.
15. Zakariah AN, Cozzi SM, Van Nuffelen M, Clausi CM, Pradier O, Vincent JL. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit Care Med 2008, 36:1507-1512. 10.1097/CCM.0b013e3181709f19, 18434897.
16. Smith EY, Charles LA, Van Cott EM. Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patients. Am J Clin Pathol 2004, 121:138-141. 10.1309/W4F7892WJE6Y1W7Y, 14750251.